SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-025950
Filing Date
2021-05-13
Accepted
2021-05-13 09:00:28
Documents
13
Period of Report
2021-05-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140763-8k_aikidopharma.htm 8-K 19340
2 BENZINGA GLOBAL SMALL CAP CONFERENCE PRESENTATION, DATED MAY 13, 2021 ea140763ex99-1_aikidopharma.htm EX-99.1 15316
3 GRAPHIC ex99-1_001.jpg GRAPHIC 101978
4 GRAPHIC ex99-1_002.jpg GRAPHIC 251316
5 GRAPHIC ex99-1_003.jpg GRAPHIC 200762
6 GRAPHIC ex99-1_004.jpg GRAPHIC 245231
7 GRAPHIC ex99-1_005.jpg GRAPHIC 284116
8 GRAPHIC ex99-1_006.jpg GRAPHIC 211274
9 GRAPHIC ex99-1_007.jpg GRAPHIC 260371
10 GRAPHIC ex99-1_008.jpg GRAPHIC 249345
11 GRAPHIC ex99-1_009.jpg GRAPHIC 304202
12 GRAPHIC ex99-1_010.jpg GRAPHIC 260499
13 GRAPHIC ex99-1_011.jpg GRAPHIC 103852
  Complete submission text file 0001213900-21-025950.txt   3442373
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 21917493
SIC: 8731 Services-Commercial Physical & Biological Research